Study Aims to Identify Melanoma Patients With High-Risk Disease

WEDNESDAY, Aug. 31, 2022 -- Patients with early-stage melanoma with low disease burden sentinel node (SN) micrometastases (American Joint Committee on Cancer [AJCC] stage IIIA disease) with SN tumor deposits ≥0.3 mm have lower survival, according...